Back

The Myo-Inositol/SMIT1 axis as a key regulator of cardiac fibrotic remodelling

17 April 2026 (08:30 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session (1) Fibrosis Delegates Premium Access Frontiers in CardioVascular Biomedicine 2026 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Angeline Geiser

Catholic University of Louvain, Brussels (Belgium)

35 More presentations in this session

Presentation thumbnail
MicroRNA changes in plasma associated with fibrous coronary plaque remodelling after PCSK9 inhibitor therapy in familial hypercholesterolemia with subclinical atherosclerosis
Doctor O. Escate Chavez (Barcelona, ES)
Abstract
Presentation thumbnail
Meis 1 synergizes with nkx2.5 to repress isl1 transcription
Mrs D. Slenczka (Berlin, DE)
Abstract
Presentation thumbnail
EZH2 controls microRNA expression in T cells in atherosclerosis
Ms X. Li (Munich, DE)
Abstract
Presentation thumbnail
Functional investigation of circular RNAs in cardiomyocyte proliferation and regeneration
Miss S. Ersoy (Hannover, DE)
Abstract
Presentation thumbnail
Role of mir-147 and let-7b in efferocytosis
Ms Q. Meng (Munich, DE)
Abstract

Access the full session

Session thumbnail
Poster session (1)

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2026

17 April 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Activated myofibroblasts promote cardiac hypertrophy and systolic dysfunction independently of cardiac fibrosis in experimental autoimmune myocarditis
27 August 2021
thumbnail
Congress Presentation
Characterization of myocardial sodium-glucose cotransporter 1 expression in humans with heart failure and reduced ejection fraction
29 August 2020
thumbnail
Congress Presentation
MicroRNA let-7a, -7e and -133a attenuate hypoxia-induced atrial fibrosis via targeting collagen expression and the JNK pathway in HL1 cardiomyocytes
27 August 2021
thumbnail
ESC Journals
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial
20 November 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources